The tumor suppressor p53 plays a pivotal role in maintaining genomic integrity, and its dysregulation is a hallmark of various hematologic malignancies, including AML, MDS, CLL, and DLBCL. This evidence concerns the gene TP53 and myelodysplastic syndrome.